| | | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $35,340,963 ) (Continued on the next page) |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | UC7AI180313 | Enhancement of Resilience of the UTHSC RBL Facility, Biosafety and Countermeasure Discovery | 000 | 2 | NIH | 7/3/2024 | $2,385,204 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R21DE031868 | Feasibility of novel Fluorine Non-thermal plasma for dental caries control | 000 | 2 | NIH | 7/1/2024 | $185,563 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01CA276152 | Targeting brain and bone metastases in metastatic breast cancer for improved patient survival | 001 | 2 | NIH | 4/24/2024 | $30,746 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01CA276152 | Targeting brain and bone metastases in metastatic breast cancer for improved patient survival | 000 | 2 | NIH | 3/20/2024 | $553,406 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01DK134937 | Prenatal Longitudinal Metabolomics Profiling for Early Childhood Growth Trajectories and Obesity Risk in a US Biracial Birth Cohort | 000 | 2 | NIH | 5/3/2024 | $723,401 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01CA281977 | Therapeutic targeting of the SWI/SNF chromatin remodeler to regulate GBM chemosensitivity | 000 | 2 | NIH | 6/3/2024 | $482,829 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01MD018174 | Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations | 002 | 2 | NIH | 6/17/2024 | $68,826 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01MD018174 | Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations | 001 | 2 | NIH | 3/22/2024 | $619,419 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01EY034425 | GRP78 signaling and retinal angiogenesis | 000 | 2 | NIH | 2/23/2024 | $511,066 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01HL166411 | Chloride channels in endothelial cells | 002 | 2 | NIH | 6/21/2024 | $50,204 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01HL166411 | Chloride channels in endothelial cells | 001 | 2 | NIH | 2/5/2024 | $564,798 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R21AG081140 | Extracellular vesicles in AD-like pathology in HIV and its potential therapeutics | 001 | 2 | NIH | 6/28/2024 | $19,250 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R21AG081140 | Extracellular vesicles in AD-like pathology in HIV and its potential therapeutics | 000 | 2 | NIH | 2/27/2024 | $173,250 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | UG3OD035519 | Retaining the diverse CANDLE cohort to advance ECHO Cohort solution-oriented research and identify early-life modifiable risk factors for obesity and mental health problems in children | 000 | 2 | NIH | 5/17/2024 | $1,411,775 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R00HL146954 | Regulation of Lymphangiogenesis by Thrombospondin 1 | 000 | 5 | NIH | 1/19/2024 | $246,788 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01GM138393 | Mechanisms of Target of Rapamycin Complex 1 Dependent Epigenetic Regulation | 000 | 3 | NIH | 6/13/2024 | $308,000 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01NS127973 | Nf2-dependent regulation of neuronal scaling in the developing cerebellum | 000 | 3 | NIH | 6/11/2024 | $413,573 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01DA054910 | Life Stress Pathways and Resilience to Substance Misuse in Black and White Youth | 000 | 3 | NIH | 6/5/2024 | $633,710 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | U01AI170019 | Radiation-Induced Paneth Cell Dysfunction | 000 | 3 | NIH | 5/23/2024 | $510,592 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01DC020465 | The Neural Organization of Taste Neophobia | 000 | 3 | NIH | 7/12/2024 | $385,000 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01ES033158 | Ionic mechanisms of toluene cerebrovascular actions | 000 | 3 | NIH | 2/7/2024 | $432,183 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01AI170115 | Virtual Patient Cohorts to Illuminate Immunologic Drivers of Influenza Severity | 000 | 3 | NIH | 5/17/2024 | $627,329 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | K23DC019440 | Early Communication in Tuberous Sclerosis Complex (TSC) and its Prediction of Autism | 000 | 3 | NIH | 6/5/2024 | $198,500 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01EY033005 | Predicting the risk of glaucoma from structural, functional, and genetic factors using artificial intelligence | 000 | 3 | NIH | 4/15/2024 | $440,335 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | F30CA265224 | Pan-cancer genomic characterization of human papillomavirus associated tumors | 000 | 3 | NIH | 5/10/2024 | $53,714 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | F30CA271570 | Identifying a transcriptional core regulatory circuitry and other critical transcription factor dependencies in H3.3 G34R/V high-grade glioma | 001 | 3 | NIH | 5/7/2024 | $1,280 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | F30CA271570 | Identifying a transcriptional core regulatory circuitry and other critical transcription factor dependencies in H3.3 G34R/V high-grade glioma | 000 | 3 | NIH | 2/12/2024 | $43,694 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01CA262112 | Determining susceptibility loci in triple negative breast cancer using a novel pre-clinical model | 001 | 3 | NIH | 4/18/2024 | $20,208 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01CA262112 | Determining susceptibility loci in triple negative breast cancer using a novel pre-clinical model | 000 | 3 | NIH | 3/5/2024 | $363,752 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01AA029270 | Defining the Role of Intestinal Calcium Channels in Alcoholic Liver Damage. | 001 | 3 | NIH | 5/10/2024 | $49,556 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01AA029270 | Defining the Role of Intestinal Calcium Channels in Alcoholic Liver Damage. | 000 | 3 | NIH | 2/24/2024 | $446,014 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | K23HL157554 | Genetic modifiers of Sickle Cell Kidney Disease | 000 | 3 | NIH | 2/2/2024 | $168,557 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | H79SM085103 | Implementing Multi-system Programs to Strengthen Attachment in Children and Families Affected by Trauma (IMPACT) | 001 | 2 | SAMHSA | 7/23/2024 | $388,863 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S. Dunlap, Suite 300 | Memphis | TN | 38163-0001 | SHELBY | USA | T7300038 | BOLING CENTER FOR DD-UAP | 00 | 32 | HRSA | 5/16/2024 | $645,000 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | D8731257 | Dental Faculty Loan Repayment | 00 | 8 | HRSA | 7/17/2024 | $64,800 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01AG068232 | Intensive Lifestyle Intervention, Metabolomics, and Risk of Frailty Fracture in Overweight or Obese Patients with Type 2 Diabetes | 000 | 4 | NIH | 5/22/2024 | $612,270 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01AI152067 | Antifungal antagonism as a cause of treatment failure for invasive mycoses | 001 | 4 | NIH | 5/23/2024 | $61,144 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01AI152067 | Antifungal antagonism as a cause of treatment failure for invasive mycoses | 000 | 4 | NIH | 2/22/2024 | $550,291 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01AI158442 | Unlocking the cidal activity of echinocandins against Aspergillus fumigatus | 000 | 4 | NIH | 3/21/2024 | $449,016 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01DK123001 | Development of a Theranostic Immunotherapy for Systemic Amyloidosis | 001 | 4 | NIH | 5/2/2024 | $26,598 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01DK123001 | Development of a Theranostic Immunotherapy for Systemic Amyloidosis | 000 | 4 | NIH | 2/21/2024 | $398,970 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01ES031656 | Genetics of epigenetic response to high circulating glucocorticoids and organophosphorus compounds | 000 | 4 | NIH | 1/12/2024 | $580,839 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01DK128129 | Ceramides and Sphingolipids as Predictors of Incident Dysglycemia | 001 | 4 | NIH | 5/7/2024 | $27,423 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01DK128129 | Ceramides and Sphingolipids as Predictors of Incident Dysglycemia | 000 | 4 | NIH | 3/4/2024 | $411,332 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01HL158846 | SK3 channel trafficking in endothelial cells | 001 | 4 | NIH | 6/12/2024 | $50,877 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01HL158846 | SK3 channel trafficking in endothelial cells | 000 | 4 | NIH | 4/25/2024 | $572,359 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01CA240447 | Dual inhibition of MDM2 and XIAP as a therapeutic strategy in cancer | 000 | 5 | NIH | 7/1/2024 | $514,428 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01DA048017 | Reduced complexity mapping of oxycodone self-administration and stress responsiveness in rats | 001 | 5 | NIH | 4/25/2024 | $34,370 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01DA048017 | Reduced complexity mapping of oxycodone self-administration and stress responsiveness in rats | 000 | 5 | NIH | 2/28/2024 | $309,338 |
|